A detailed history of Transatlantique Private Wealth LLC transactions in Amgen Inc stock. As of the latest transaction made, Transatlantique Private Wealth LLC holds 3,469 shares of AMGN stock, worth $1.11 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
3,469
Previous 3,009 15.29%
Holding current value
$1.11 Million
Previous $855,000 26.67%
% of portfolio
0.45%
Previous 0.38%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $120,865 - $146,882
460 Added 15.29%
3,469 $1.08 Million
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $35,490 - $42,841
132 Added 4.59%
3,009 $855,000
Q3 2023

Jun 25, 2024

SELL
$218.65 - $271.46 $28,861 - $35,832
-132 Reduced 4.39%
2,877 $773,000
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $874 - $1,085
4 Added 0.14%
2,877 $773,000
Q2 2023

Jun 25, 2024

BUY
$214.27 - $253.37 $32,783 - $38,765
153 Added 5.63%
2,873 $637,000
Q2 2023

Aug 10, 2023

BUY
$214.27 - $253.37 $32,783 - $38,765
153 Added 5.63%
2,873 $638,000
Q1 2023

Jun 25, 2024

SELL
$225.79 - $275.2 $65,253 - $79,532
-289 Reduced 9.6%
2,720 $657,000
Q1 2023

May 05, 2023

BUY
$225.79 - $275.2 $24,611 - $29,996
109 Added 4.17%
2,720 $658,000
Q4 2022

Jun 25, 2024

SELL
$229.03 - $291.01 $91,153 - $115,821
-398 Reduced 13.23%
2,611 $685,000
Q4 2022

Feb 06, 2023

BUY
$229.03 - $291.01 $27,483 - $34,921
120 Added 4.82%
2,611 $686,000
Q3 2022

Nov 04, 2022

SELL
$224.46 - $253.15 $19,976 - $22,530
-89 Reduced 3.45%
2,491 $561,000
Q2 2022

Aug 01, 2022

BUY
$230.71 - $256.74 $595,231 - $662,389
2,580 New
2,580 $628,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Transatlantique Private Wealth LLC Portfolio

Follow Transatlantique Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transatlantique Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transatlantique Private Wealth LLC with notifications on news.